P388D1, and human monocyte-derived macrophages. Immunoglobulin Gl antibodies seemed to be a preferred isotype.
Macrophages are one of the major lines of host defense in the early stages of infections (1). In particular, it has been demonstrated that Pseudomonas aeruginosa opsonized by specific immunoglobulins can be taken up and killed by macrophages (7) . Our earlier studies indicated that monoclonal antibodies directed against a Pseudomonas outer membrane protein (protein F) were protective in mouse infection models, although they failed to enhance complementmediated killing of the bacteria (2). This implied that the monoclonal antibodies are acting to opsonize P. aeruginosa for phagocytosis in the mouse infection model.
In this study, we show that protein F monoclonal antibodies can opsonize P. aeruginosa M2 (10) (12) .
To investigate the time course of bacterial uptake in the presence or absence of monoclonal antibody, the visual phagocytosis assay (9) was performed as described in the * Corresponding author. legend to Fig. 1 and was halted at four time points for assessment. The data obtained from two separate experiments showed that the saline control produced a gradual increase in phagocytosis from 0 to 30 min. After 30 min, no further uptake was observed for the duration of the experiment (data not shown). In the presence of antibody MA2-10 (5), on the other hand, good uptake was observed almost immediately. Uptake kinetics were complex, in that the number of bacteria per macrophage leveled out between 30 and 60 min but increased significantly after 60 min. This produced a biphasic time course of bacterial association. From the results of these experiments, we chose to halt our P388D1 phagocytic assays at a time at which the change in the average number of bacteria per phagocyte in the negative controls was static (90 min).
With the negative controls, saline and MA1-3 (a monoclonal antibody directed against an outer membrane epitope that was not surface exposed [3] ), most of the macrophages had phagocytosed few or no bacteria after 90 min (Fig. 1) . This resulted in a distribution with a large peak at zero and a very low, short shoulder region. When a monoclonal antibody specific for P. aeruginosa protein F was added, this major peak shifted over to approximately 5, 7, and 11 bacteria per cell for human peripheral blood monocytes and P388D1 and mouse peritoneal macrophages, respectively. The shoulder region also lengthened considerably.
All five anti-F (5) monoclonal antibodies caused significantly increased bacterial association over the negative control with all cell types in most assays (Table 1) . Substantial assay-to-assay variability was observed with human peripheral blood monocytes (apparently depending on the donor), as reflected in the high standard deviations. Interestingly, the most-opsonic antibodies were of the immunoglobulin Gl In conclusion, we have demonstrated that monoclonal antibodies directed against protein F are capable of opsonizing P. aeruginosa for phagocytosis by all three macrophage cell types tested. This suggests that the mechanism of protection afforded by monoclonal antibodies in vivo (2) is through opsonization for phagocytosis. The specificity and effectiveness of these anti-F monoclonal antibodies provides them with substantial potential as immunotherapeutic agents. 
